Fukuda, Tsuyoshi
Thompson, Brian R.
Brouwers, Bram
Qian, Hui-Rong
Wang, Wei
Morse, Bridget L.
LaBell, Elizabeth Smith
Durham, Timothy B.
Konig, Manige
Haupt, Axel
Benson, Charles T.
MacKrell, James
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 5 March 2025
Accepted: 25 April 2025
First Online: 13 May 2025
Declarations
:
: Jim MacKrell, Bram Brouwers, Timothy B Durham, Wei Wang, Charles T Benson, Axel Haupt, Bridget Morse, Brian Thompson, Hui-Rong Qian, and Elizabeth Smith LaBell are the employees and stakeholders of Eli Lilly and Company. Manige Konig and Tsuyoshi Fukuda were employees of Eli Lilly and Company at the time of this study.
: The study was conducted in compliance with the principles of the Declaration of Helsinki, the Council for International Organizations of Medical Sciences International Ethical Guidelines, and the International Council for Harmonization Good Clinical Practice guidelines. The protocol was reviewed and approved by the Midlands Independent Review Board and the study was registered on ClinicalTrials.gov (NCT04559568). All participants provided written informed consent before participation.